Geneos Wealth Management’s JPMorgan International Research Enhanced Equity ETF JIRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
19,078
-240
-1% -$19.3K 0.03% 438
2026
Q1
$1.46M Sell
19,318
-5,886
-23% -$460K 0.03% 414
2025
Q4
$1.89M Sell
25,204
-339
-1% -$25.3K 0.05% 360
2025
Q3
$1.88M Sell
25,543
-504
-2% -$36.1K 0.05% 358
2025
Q2
$1.84M Buy
26,047
+695
+3% +$46.3K 0.05% 386
2025
Q1
$1.62M Buy
25,352
+14,072
+125% +$882K 0.05% 346
2024
Q4
$660K Buy
+11,280
New +$705K 0.02% 511

Other funds holding JIRE

Geneos Wealth Management's JIRE Position: Q2 2026 in Review

Geneos Wealth Management reduced its JPMorgan International Research Enhanced Equity ETF (JIRE) stake by 1.2% in Q2 2026, selling an estimated $19.3K and leaving 19,078 shares worth $1.57M. The position accounts for 0.03% of the portfolio, ranked #438.

Geneos Wealth Management first reported a position in JIRE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.89M in Q4 2025. 350 funds tracked by Wall St. Rank hold JIRE as of Q2 2026.

  • Geneos Wealth Management held 19,078 shares of JPMorgan International Research Enhanced Equity ETF worth $1.57M as of Q2 2026.
  • Geneos Wealth Management sold 240 JPMorgan International Research Enhanced Equity ETF shares in Q2 2026, an estimated $19.3K.
  • JPMorgan International Research Enhanced Equity ETF made up 0.03% of Geneos Wealth Management's portfolio in Q2 2026, its #438 holding.
  • Geneos Wealth Management first reported a position in JPMorgan International Research Enhanced Equity ETF in Q4 2024 and has held it in 7 quarters since.
  • Geneos Wealth Management's JPMorgan International Research Enhanced Equity ETF position peaked at $1.89M in Q4 2025.
  • 350 funds tracked by Wall St. Rank held JPMorgan International Research Enhanced Equity ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.